DK162813C - Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler - Google Patents

Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler

Info

Publication number
DK162813C
DK162813C DK242082A DK242082A DK162813C DK 162813 C DK162813 C DK 162813C DK 242082 A DK242082 A DK 242082A DK 242082 A DK242082 A DK 242082A DK 162813 C DK162813 C DK 162813C
Authority
DK
Denmark
Prior art keywords
preparation
inhibiting
growth
procedure
neoplastic cells
Prior art date
Application number
DK242082A
Other languages
Danish (da)
English (en)
Other versions
DK242082A (da
DK162813B (da
Inventor
Stanislaw R Burzynski
Original Assignee
Stanislaw R Burzynski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanislaw R Burzynski filed Critical Stanislaw R Burzynski
Publication of DK242082A publication Critical patent/DK242082A/da
Publication of DK162813B publication Critical patent/DK162813B/da
Application granted granted Critical
Publication of DK162813C publication Critical patent/DK162813C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/834—Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK242082A 1981-07-02 1982-05-28 Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler DK162813C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27972881A 1981-07-02 1981-07-02
US27972881 1981-07-02
US33038381 1981-12-15
US06/330,383 US4470970A (en) 1981-07-02 1981-12-15 Purified antineoplaston fractions and methods of treating neoplastic disease

Publications (3)

Publication Number Publication Date
DK242082A DK242082A (da) 1983-01-03
DK162813B DK162813B (da) 1991-12-16
DK162813C true DK162813C (da) 1992-05-04

Family

ID=26959856

Family Applications (2)

Application Number Title Priority Date Filing Date
DK242082A DK162813C (da) 1981-07-02 1982-05-28 Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler
DK143491A DK143491A (da) 1981-07-02 1991-08-06 Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK143491A DK143491A (da) 1981-07-02 1991-08-06 Fremgangsmaade til fremstilling af 3-oen-phenylacetylaminopiperidinaa-2,6-dion

Country Status (14)

Country Link
US (1) US4470970A (ja)
EP (1) EP0069232B1 (ja)
JP (3) JPH0729925B2 (ja)
AU (1) AU551109B2 (ja)
CA (1) CA1188218A (ja)
DE (1) DE3273952D1 (ja)
DK (2) DK162813C (ja)
ES (1) ES8502417A1 (ja)
HK (1) HK30289A (ja)
IL (1) IL65960A (ja)
MY (1) MY102918A (ja)
NO (1) NO163595C (ja)
NZ (1) NZ200805A (ja)
SG (1) SG4489G (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
AU7742491A (en) * 1990-04-12 1991-11-11 Stereo-Chemical Genetics, Inc. Synthetic piperidinediones with cytostatic activity
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer
EP0567613B1 (en) * 1991-10-21 2002-02-20 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Compositions for therapy and prevention of cancer
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
US5783605A (en) * 1995-02-27 1998-07-21 Kuo; Sheng-Chu Helper inducers for differentiation therapy and chemoprevention of cancer
CA2254772C (en) * 1996-05-14 2004-01-27 Stanislaw R. Burzynski Liposomal antineoplaston therapies with markedly improved antineoplastic activity
EP2298350A3 (en) * 1996-07-26 2011-06-08 Susan P. Perrine Composition comprising an inducing agent and an anti-viral agent for the treatment of viral disorders
US6258849B1 (en) * 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
AU1553799A (en) * 1998-12-18 2000-07-12 Chang, Ming-Lieh Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
US6987131B1 (en) * 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
NZ538405A (en) * 2002-08-01 2007-12-21 Aesgen Inc Improved treatment of cancer with glutamine and carbohydrate
US7087219B2 (en) * 2003-05-28 2006-08-08 Stanislaw R. Burzynski Toothpaste containing anticancer agents
US20060246016A1 (en) * 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE463549A (ja) *
GB2003887A (en) * 1977-09-06 1979-03-21 Nyegaard & Co As Isolation of peptides from urine
JPS57115330A (en) * 1981-01-08 1982-07-17 Toshiba Mach Co Ltd Forming process for thick plastic products and its metal mold
JP2897285B2 (ja) * 1989-10-19 1999-05-31 東洋紡績株式会社 熱可塑性樹脂フィルム積層物

Also Published As

Publication number Publication date
AU8423982A (en) 1983-01-06
US4470970A (en) 1984-09-11
NO163595C (no) 1990-06-27
NO163595B (no) 1990-03-19
JPH0780764B2 (ja) 1995-08-30
ES512894A0 (es) 1985-01-01
EP0069232B1 (en) 1986-10-29
HK30289A (en) 1989-04-21
DK242082A (da) 1983-01-03
JPS5810521A (ja) 1983-01-21
NO822218L (no) 1983-01-03
CA1188218A (en) 1985-06-04
IL65960A0 (en) 1982-09-30
JPH0739390B2 (ja) 1995-05-01
ES8502417A1 (es) 1985-01-01
JPH0558886A (ja) 1993-03-09
SG4489G (en) 1989-05-26
JPH0532548A (ja) 1993-02-09
DK143491D0 (da) 1991-08-06
CA1262907C (ja) 1989-11-14
JPH0729925B2 (ja) 1995-04-05
NZ200805A (en) 1986-08-08
EP0069232A2 (en) 1983-01-12
DK162813B (da) 1991-12-16
DE3273952D1 (en) 1986-12-04
DK143491A (da) 1991-08-06
IL65960A (en) 1985-11-29
MY102918A (en) 1993-03-31
EP0069232A3 (en) 1984-07-04
AU551109B2 (en) 1986-04-17

Similar Documents

Publication Publication Date Title
DK162813C (da) Fremgangsmaade til fremstilling af et praeparat til at haemme vaeksten af neoplastiske celler
DK195083A (da) Fremgangsmaade til fremstilling af et glaucomapraeparat
DK260183D0 (da) Fremgangsmade til fremstilling af indolderivater
DK112482A (da) Fremgangsmaade til dyrkning af forankringsafhaengige celler
DK158820C (da) Fremgangsmaade til fremstilling af vandingsroer
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK1584D0 (da) Fremgangsmade til fremstilling af et gitterkernesandwichelement
DK150234C (da) Fremgangsmaade til fremstilling af en vandtaet overfladebelaegning
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK162586C (da) Fremgangsmaade til fremstilling af en biaksialt orienteret beholder
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK108783A (da) Fremgangsmaade til fremstilling af triglycerider
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK105387D0 (da) Fremgangsmaade til fremstilling af uforgaengeliggjorte primaere celler
DK44587D0 (da) Fremgangsmaade til fremstilling af farvestoffer af plantedele
DK152043C (da) Fremgangsmaade til fremstilling af et ranitidin
DK384382A (da) Fremgangsmaade til fremstilling af et lagringsbestandigt braendsel
DK535482A (da) Fremgangsmaade til fremstilling af thioalkanoylcarnitiner
DK567382A (da) Fremgangsmaade til fremstilling af dialkylsulfider
DK51182A (da) Fremgangsmaade til fremstilling af et kombinationspraeparat
DK155682A (da) Fremgangsmaade til fremstilling af et psykotropt laegemiddel
DK145182A (da) Fremgangsmaade til fremstilling af amino-pyridiner
DK114782A (da) En saerlig fremgangsmaade til fremstilling af triazolylvinylketonforbindelser
DK390481A (da) Fremgangsmaade til fremstilling af et pektinesterasepraeparat
DK215082A (da) Fremgangsmaade til fremstilling af 2-iminotiazolidinderivater

Legal Events

Date Code Title Description
PUP Patent expired